138 related articles for article (PubMed ID: 23620269)
1. Genetic variants in 2q31 and 5p15 are associated with aggressive benign prostatic hyperplasia in a Chinese population.
Qi J; Tian L; Chen Z; Wang L; Tao S; Gu X; Na R; Jiao Y; Kang J; Zheng S; Xu J; Sun J
Prostate; 2013 Aug; 73(11):1182-90. PubMed ID: 23620269
[TBL] [Abstract][Full Text] [Related]
2. Re: genetic variants in 2q31 and 5p15 are associated with aggressive benign prostatic hyperplasia in a Chinese population.
Kaplan SA
J Urol; 2014 Jun; 191(6):1825-6. PubMed ID: 25280305
[No Abstract] [Full Text] [Related]
3. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
Qian X; Xu D; Liu H; Lin X; Yu Y; Kang J; Sheng X; Xu J; Zheng S; Xu D; Qi J
Aging Male; 2017 Dec; 20(4):250-256. PubMed ID: 28787260
[TBL] [Abstract][Full Text] [Related]
4. LILRA3 is associated with benign prostatic hyperplasia risk in a Chinese Population.
Jiao Y; Wang L; Gu X; Tao S; Tian L; Na R; Chen Z; Kang J; Zheng SL; Xu J; Sun J; Qi J
Int J Mol Sci; 2013 Apr; 14(5):8832-40. PubMed ID: 23615473
[TBL] [Abstract][Full Text] [Related]
5. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
Na R; Helfand BT; Chen H; Conran CA; Crawford SE; Hayward SW; Tammela TLJ; Hoffman-Bolton J; Zheng SL; Walsh PC; Schleutker J; Platz EA; Isaacs WB; Xu J
Prostate; 2017 Aug; 77(11):1213-1220. PubMed ID: 28656603
[TBL] [Abstract][Full Text] [Related]
6. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese.
Hung SC; Chang LW; Hsiao TH; Lin GC; Wang SS; Li JR; Chen IC
Hum Genomics; 2024 May; 18(1):49. PubMed ID: 38778357
[TBL] [Abstract][Full Text] [Related]
7. Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.
Nikolić ZZ; Branković AS; Savić-Pavićević DL; Preković SM; Vukotić VD; Cerović SJ; Filipović NN; Tomović SM; Romac SP; Brajušković GN
Clin Transl Sci; 2014 Aug; 7(4):307-13. PubMed ID: 24422606
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility loci associations with prostate cancer risk in northern Chinese men.
Wang NN; Xu Y; Yang K; Wei D; Zhang YG; Liu M; Shi XH; Liang SY; Sun L; Zhu XQ; Yang YG; Tang L; Zhao CX; Wang X; Chen X; Hui J; Zhang YH; Zhu L; Yang F; Zhang YR; Yang Z; Wang JY
Asian Pac J Cancer Prev; 2013; 14(5):3075-8. PubMed ID: 23803082
[TBL] [Abstract][Full Text] [Related]
9. Association of a common variant at 10q26 and benign prostatic hyperplasia aggressiveness in han chinese descent.
Gu X; Huang T; Xu D; Duan L; Jiao Y; Kang J; Zheng SL; Xu J; Sun J; Qi J
Biochem Res Int; 2013; 2013():820849. PubMed ID: 23984071
[TBL] [Abstract][Full Text] [Related]
10. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
[TBL] [Abstract][Full Text] [Related]
11. Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer.
Glaser A; Shi Z; Wei J; Lanman NA; Ladson-Gary S; Vickman RE; Franco OE; Crawford SE; Lilly Zheng S; Hayward SW; Isaacs WB; Helfand BT; Xu J
Eur Urol Open Sci; 2022 Sep; 43():54-61. PubMed ID: 36353071
[TBL] [Abstract][Full Text] [Related]
12. [Susceptibility to prostate cancer in Han Chinese: single nucleotide polymorphism analysis of 1 667 cases].
Cui Y; Shi YC; Shen H; Fan YZ; Cao WZ; Xie JJ; Su HQ; Shao Q
Zhonghua Nan Ke Xue; 2012 Dec; 18(12):1069-74. PubMed ID: 23405784
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
Kim S; Shin C; Jee SH
Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
[TBL] [Abstract][Full Text] [Related]
14. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians.
Fawzy MS; Elfayoumi AR; Mohamed RH; Fatah IRA; Saadawy SF
Biochem Genet; 2016 Jun; 54(3):326-336. PubMed ID: 26920155
[TBL] [Abstract][Full Text] [Related]
16. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
18. Common variants at 8q24 are associated with prostate cancer risk in Serbian population.
Branković AS; Brajušković GN; Mirčetić JD; Nikolić ZZ; Kalaba PB; Vukotić VD; Tomović SM; Cerović SJ; Radojičić ZA; Savić-Pavićević DL; Romac SP
Pathol Oncol Res; 2013 Jul; 19(3):559-69. PubMed ID: 23532531
[TBL] [Abstract][Full Text] [Related]
19. Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes.
Ruan X; Huang D; Huang J; Tsu JH; Na R
J Transl Med; 2023 Jul; 21(1):446. PubMed ID: 37415201
[TBL] [Abstract][Full Text] [Related]
20. Relationship of oestrogen receptor alpha gene polymorphisms with risk for benign prostatic hyperplasia and prostate cancer in Chinese men.
Han Z; Zhang L; Zhu R; Luo L; Zhu M; Fan L; Wang G
Medicine (Baltimore); 2017 Mar; 96(13):e6473. PubMed ID: 28353585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
